Skip to main content
. 2012 Dec 18;7(12):e52096. doi: 10.1371/journal.pone.0052096

Figure 4. Effects of drug intervention Tol-DCs on islet allograft survival.

Figure 4

A) mDC+VAF347. B) imDC or mDC with/without VAF347. VAF347: VAF347 is a low-molecular-weight compound, which can modify immune responses through induction of Tol-DC, and activating AhR resulted in induction of Foxp3+Treg cells.